Scientific Online Resource System

Scripta Scientifica Medica

Quality of life and regular diet in patients with chronic kidney disease

Svetla Staykova, Petar Petrov, Lili Grudeva

Abstract

Introduction: Chronic kidney disease (CKD) is characterized by a reduced rate of glomerular filtration (GF), under 60 mL/min/1.73 m2, and/or laboratory data, and/or image data for kidney damage, present for more than 3 months. According to recent data, nearly 8.7% of the world population suffer from CKD with different etiology. CKD is a progressive health condition that can result in an end stage renal disease (ESRD).

Materials and Methods: The quality of life (QoL) of these patients is of utmost importance and is related to their functional activity, well-being and overall perception of their health in a physical, psychological and social aspect. A direct link between QoL, morbidity rate and death rate exists. It has been established that patients with CKD have a significantly lower QoL compared to healthy people, which becomes clearer during the more advanced stages of the disease. Physical activity decreases progressively with the progression of kidney disease.

Results: Sociodemographic, clinical and laboratory risk factors have been established in the population of dialysis patients, which definitely leads to a change in QoL. Malnutrition, which is observed in patients with CKD, can also contribute to a decline in their quality of life. Its occurrence results from a reduced food intake, increased protein consumption and altered endocrine function of the kidneys. Oral intake of nutrients raises the chances of treating protein-energy wasting (PEW) in patients with ESRD.

Conclusion: Conducting dietary consultations, as well as preparing individual diets to meet a patient’s specific needs, will increase their quality of life.


Keywords

chronic kidney disease, protein energy waste, quality of life, hemodialysis, peritoneal dialysis

Full Text


References

Sahay M, Sahay R, Baruah MP, Pradesh A. Nutrition in chronic kidney disease. J Med Nutr Nutraceut. 2014; 3(1):11-8.

Neto JF, Ferraz MB, Cendoroglo M, Draibe S, Yu L, Sesso R. Quality of life at the initiation of maintenance dialysis treatment--a comparison between the SF-36 and the KDQ questionnaires. Qual Life Res. 2000;9(1):101–7. doi:10.1023/A:1008918609281.

Condé SA, Fernandes N, Santos FR, Chouab A, Mota MM, Bastos MG. Cognitive decline, depression and quality of life in patients at different stages of chronic kidney disease. J Bras Nefrol. 2010;32(3):242–8.

Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15(7):953-60. doi:10.1093/ndt/15.7.953.

Carrero JJ1, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2):77-90. doi: 10.1053/j.jrn.2013.01.001.

Stenvinkel P, Chung SH, Heimbürger O, Lindholm B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int. 2001;21 Suppl 3:S157-62.

Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011 Oct;80(8):806-21. doi: 10.1038/ki.2011.198.

Kim SB, Chi HS, Park JS, Hong CD, Yang WS. Effect of increasing serum albumin on plasma D‐dimer, von Willebrand factor, and platelet aggregation in CAPD patients. Am J Kidney Dis. 1999; 33(2):312–7. doi: 10.1016/s0272-6386(99)70306-9.

Mehrotra, R, Kopple J. Causes of protein–energy malnutrition in chronic renal failure. In: Kopple J, Massry S, editors Nutritional management of renal disease. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003.

Campbell KL, Ash S, Bauer JD. The impact of nutrition intervention on quality of life in pre-dialysis chronic kidney disease patients. Clin Nutr. 2008;27(4):537-44. doi: 10.1016/j.clnu.2008.05.002.

Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome—the heart of the matter. Nephrol Dial Transplant. 2002;17 Suppl 11:28-31. doi: 10.1093/ndt/17.suppl_11.28.

Baltzan MA, Shoker AS. Malnutrition and dialysis (letter). Kidney Int. 1998; 54(3):999.

Kaysen GA, Eiserich, JP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol. 2004; 15:538–48.

Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney Int. 2008;74(3):393, doi: 10.1038/sj.ki.5002585.

Fouque D, Pelletier S, Mafra D, Chauveau P. Nutrition and chronic kidney disease, Kidney Int. 2011;80(4):348-57. doi: 10.1038/ki.2011.118.

Soejima A, Matsuzawa N, Miyake N, Karube M, Fukuoka K, Nakabayashi K, et al. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. Clin Nephrol. 1999; 51(2):92–7.

Kessler P, Popp R, Busse R, Schini‐Kerth VB. Proinflammatory mediators chronically downregulate the formation of the endothelium‐derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP‐dependent mechanism. Circulation. 1999;99(14):1878–84. doi:10.1161/01.CIR.99.14.1878.

Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintance hemodialysis patient. Kidney Int. 1998; 54(2): 627-36. doi: 10.1046/j.1523-1755.1998.00032.x.

Kalantar-Zadeh K, Block G, McAllister, CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004; 80(2):299–307.

Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005; 20(9):1880–8. doi: 10.1093/ndt/gfh941.

Kalender B, Ozdemir AC, Dervisoglu E, Ozdemir O. Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation. Int J Clin Pract. 2007;61(4):569–76. doi: 10.1111/j.1742-1241.2006.01251.x.

Spiegel BM, Melmed G, Robbins S, Esrailian E. Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol. 2008;3(6):1759–68. doi: 10.2215/CJN.00820208.

Herselman M, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D. Protein–energy malnutrition as a risk factor for increased morbidity in long-term hemodialysis patients. J Ren Nutr. 2000; 10(1):7–15. doi: 10.1016/s1051-2276(00)90017-7.

Mingardi G, Cornalba L, Cortinovis E, Ruggiata R, Mosconi P, Apolone G. Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant. 1999;14(6):1503–10. doi: 10.1093/ndt/14.6.1503.

Cruz MC1, Andrade C, Urrutia M, Draibe S, Nogueira-Martins LA, Sesso Rde C. Quality of life in patients with chronic kidney disease. Clinics (Sao Paulo). 2011;66(6):991-5. doi: 10.1590/s1807-59322011000600012.




DOI: http://dx.doi.org/10.14748/ssm.v51i3.6213

Refbacks

Article Tools
Email this article (Login required)
About The Authors

Svetla Staykova
Medical University of Varna
Bulgaria

Second Departmentof Internal diseases, Faculty of Medicine;

Clinic of  Nephrology and Dialysis, St. Marina University Hospital

Petar Petrov
Medical University of Varna

Second Departmentof Internal diseases, Faculty of Medicine;

Clinic of  Nephrology and Dialysis, St. Marina University Hospital

Lili Grudeva
Medical University of Varna

Clinic of  Hepatogastroenterology, St. Marina University Hospital

Font Size


|